-
Instructions for PharmacistPage 1Page 2
NDC 70332-102-01
For Prescription Compounding Only
Rx only
RapidPaq™
CYCLOPHENE™
(5% cyclobenzaprine hydrochloride topical cream kit)RapidPaq™ kits provide a convenient approach to rapidly prepare prescription medications, as all components are pre-measured. This kit is manufactured according to US FDA current Good Manufacturing Practices (cGMP).
Description:
This kit contains active and inactive materials to prepare approximately 111.2 grams of Cyclobenzaprine Hydrochloride topical cream. This kit may only be used for prescription compounding by an appropriate licensed medical professional, in response to a physician's prescription, to create a medication tailored to the specialized needs of an individual patient.Active Ingredients:
- 5.6 g Cyclobenzaprine Hydrochloride [equivalent to 4.9 g Cyclobenzaprine]Inactive Ingredients:
- 100 g RapidPaq Cream Base (D. l Water, Cetearyl Alcohol, Cyclomethicone, Polysorbate-60, Sorbitol, Phenoxyethanol(and)ethylhexylglycerin,
Tocopheryl Acetate, Aloe Barbadensis, Disodium EDTA)
- 5.6 Ethoxy Diglycol
- Spatula
- InstructionsPharmacist Instructions for Preparation
1 Remove and Inspect the Contents of the Kit
Ensure that all components are present. Ensure that the safety seals are present on the Cyclobenzaprine Hydrochloride, ethoxy diglycol and RapidPaq Cream Base. If components are missing or the safety seals are not intact do not use the kit.
2 Prepare for Mixing
Wear gloves and eye protection during mixing operations. Remove the cap and seal from the RapidPaq Cream Base. Break the perforated seal and remove the cap from the Cyclobenzaprine Hydrochloride and ethoxy diglycol.
3 Dissolve the Cyclobenzaprine Hydrochloride
Using a spatula make a well in the center of the RapidPaq Cream Base. Transfer approximately half of the ethoxy diglycol to the Cyclobenzaprine Hydrochloride bottle. Cap the Cyclobenzaprine Hydrochloride bottle and shake to ensure that all residue Cyclobenzaprine Hydrochloride has been dissolved. Pour the contents into the RapidPaq Cream Base. Repeat this step with the remaining ethoxy diglycol.
4 Complete the Mixing Process
Using the spatula, mix the RapidPaq Base jar that now contains the ethoxy diglycol and cyclobenazprine hydrochloride ingredients thoroughly for about 2 minutes or until fully dissolved.
5 Relabel the Resulting Cream
Label the resulting topical cream as required for prescription products. Ensure that the original RapidPaq Cream Base label is removed or obscured, since the original label is no longer accurate once the cream is prepared.
Discard the spatula.
Store the unused kit at room temperature of 15-30°C (59-86°F). Once prepared, store the topical cream between 15-30°C (59-86°F). The final cream is stable for up to eight weeks.
U.S. Patents Pending
Repackaged and Distributed by:
California Pharmaceuticals, LLC
768 Calle Plano
Camarillo, CA 93012California
PHARMACEUTICALS LLCCS107-A1 rev 3
-
Cyclobenzaprine Hydrochloride product label
Do not use if saety seal is broken
Cyclobenzaprine Hydrochloride
1-propanamine, 3-(5H-dibenzo[a,d]cycloheptenn-5-ylidene)-N,N-dimethyl-, hydrochloride
RxOnly
CAS # 6202-23-9
Net contents 5.6 g
Repackaged by:
California Pharmaceuticals, LLC
Camarillo, CA 93012
California
PHARMACEUTICALS LLC
CS104-A1 rev 1
-
RapidPaq Cream Base product label
Do not use if seal is broken
RapidPaq™ Cream base
Net contents: 100 g
Ingredients: (D.l Water, Cetearyl Alcohol, Cyclomethicone, Polysorbate-60, Sorbitol, Phenoxyethanol(and)ethylhexylglycerin, Tocopheryl Acetate,
Aloe barbadensis, Disodium EDTA.)
RX Only
Manufactured for California Pharmaceyticals, LLC, Camarillo, CA 93012
-
CYCLOPHENE Kit product label
NDC 70332-102-01
Rx only
RapidPaq™
Kit for Topical Cream
CYCLOPHENE™
(5% cyclobenzaprine hydrochloride topical cream kit)
Muscle relaxant
Store at room temperature,
15-30°C (59-86°F)
Description:
This kit contains active and inactive materials to prepare approximately 111.2 grams of Cyclobenzaprine Hydrochloride topical cream. This kit may only be used for prescription compounding by an appropriate licensed medical professional, in response to a physician's prescription, to create a medication tailored to the specialized needs of an individual patient.
Active ingredient
- 5.6 g Cyclobenzaprine Hydrochloride USP [equivalent to 4.9 g Cyclobenzaprine]
Inactive Ingredients:
- 100 g RapidPaq Cream Base(D.l Water, Cetearyl Alcohol, Cyclomethicone, Polysorbate-60, Sorbitol, Phenoxyethanol(and) ethylhexylglycerin,
Tocopheryl Acetate, Aloe Barbadensis, Disodium EDTA)
- 5.6 g Ethoxy Diglycol
- Spatula
- Instructions
U.S. Patents Pending
Do not use if safety seal is broken
California
PHARMACEUTICALS LLC
Repacked and Distributed By;
Caifornis Pharmaceuticals, LLC
768 Calle Plano
Camarillo, CA 93012
CS 108-A1 rev 1
-
INGREDIENTS AND APPEARANCE
CYCLOPHENE
cyclophene kitProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:70332-102 Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:70332-102-01 1 in 1 KIT 01/01/2016 Quantity of Parts Part # Package Quantity Total Product Quantity Part 1 1 BOTTLE 5.6 g Part 2 1 BOTTLE 5.6 g Part 3 1 JAR 100 g Part 1 of 3 ETHOXY DIGLYCOL
diethylene glycol monoethyl ether liquidProduct Information Route of Administration TOPICAL Inactive Ingredients Ingredient Name Strength DIETHYLENE GLYCOL MONOETHYL ETHER (UNII: A1A1I8X02B) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 5.6 g in 1 BOTTLE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 01/01/2016 Part 2 of 3 CYCLOBENZAPRINE HYDROCHLORIDE
cyclobenzaprine hydrochloride powderProduct Information Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CYCLOBENZAPRINE HYDROCHLORIDE (UNII: 0VE05JYS2P) (CYCLOBENZAPRINE - UNII:69O5WQQ5TI) CYCLOBENZAPRINE HYDROCHLORIDE 5.6 g in 5.6 g Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 5.6 g in 1 BOTTLE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 01/01/2016 Part 3 of 3 RAPIDPAQ CREAM BASE
rapidpaq cream base creamProduct Information Route of Administration TOPICAL Inactive Ingredients Ingredient Name Strength PHENOXYETHANOL (UNII: HIE492ZZ3T) .ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0) CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S) ETHYLHEXYLGLYCERIN (UNII: 147D247K3P) CYCLOMETHICONE 5 (UNII: 0THT5PCI0R) EDETATE DISODIUM (UNII: 7FLD91C86K) WATER (UNII: 059QF0KO0R) POLYSORBATE 60 (UNII: CAL22UVI4M) SORBITOL (UNII: 506T60A25R) ALOE VERA LEAF (UNII: ZY81Z83H0X) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 100 g in 1 JAR; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 01/01/2016 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 01/01/2016 Labeler - California Pharmaceuticals LLC (021420944) Registrant - California Pharmaceuticals LLC (021420944) Establishment Name Address ID/FEI Business Operations California Pharmaceuticals LLC 021420944 manufacture(70332-102) , repack(70332-102)